These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31221352)

  • 1. Transvenous Lead Extraction in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Barakat AF; Zmaili MA; Tarakji KG; Shah S; Abdur Rehman K; Martin DO; Brunner MP; Saliba WI; Kanj M; Ballout J; Baranowski B; Cantillon D; Niebauer M; Callahan T; Dresing T; Rickard J; Lindsay BD; Wilkoff BL; Wazni OM; Hussein AA
    JACC Clin Electrophysiol; 2019 Jun; 5(6):665-670. PubMed ID: 31221352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter experience with transvenous lead extraction in arrhythmogenic right ventricular cardiomyopathy (ARVC).
    Maytin M; Henrikson CA; Schaerf RH; Epstein LM; John RM
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1280-3. PubMed ID: 23786517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution in transvenous extraction of pacemaker and implantable cardioverter defibrillator leads using a mechanical dilator sheath.
    Oto A; Aytemir K; Canpolat U; Yorgun H; Şahiner L; Kaya EB; Kabakçi G; Tokgözoğlu L
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):834-40. PubMed ID: 22486778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience with the TightRail™ Rotating Mechanical Dilator Sheath for transvenous lead extraction.
    Aytemir K; Yorgun H; Canpolat U; Şahiner ML; Kaya EB; Evranos B; Özer N
    Europace; 2016 Jul; 18(7):1043-8. PubMed ID: 26467403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy.
    Herman AR; Gardner M; Steinberg C; Yeung-Lai-Wah JA; Healey JS; Leong-Sit P; Krahn AD; Chakrabarti S
    Heart Rhythm; 2016 Oct; 13(10):1964-70. PubMed ID: 27321245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for sudden death in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Tadros R; Talajic M; Rivard L; Abadir S; Khairy P
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):653-64. PubMed ID: 25947965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous lead extraction at the time of cardiac implantable electronic device upgrade: Complexity, safety, and outcomes.
    Barakat AF; Wazni OM; Tarakji K; Saliba WI; Nimri N; Rickard J; Brunner M; Bhargava M; Kanj M; Baranowski B; Martin DO; Cantillon D; Callahan T; Dresing T; Niebauer M; Chung M; Lindsay BD; Wilkoff B; Hussein AA
    Heart Rhythm; 2017 Dec; 14(12):1807-1811. PubMed ID: 28842225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical diagnosis and management strategies in arrhythmogenic right ventricular cardiomyopathy.
    Corrado D; Buja G; Basso C; Thiene G
    J Electrocardiol; 2000; 33 Suppl():49-55. PubMed ID: 11265736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Calkins H; Corrado D; Marcus F
    Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy.
    Boriani G; Artale P; Biffi M; Martignani C; Frabetti L; Valzania C; Diemberger I; Ziacchi M; Bertini M; Rapezzi C; Parlapiano M; Branzi A
    Heart Vessels; 2007 May; 22(3):184-92. PubMed ID: 17533523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies.
    Corrado D; Basso C; Nava A; Thiene G
    Cardiol Rev; 2001; 9(5):259-65. PubMed ID: 11520449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high-volume center experience.
    Hayashi K; Callahan T; Rickard J; Baranowski B; Martin DO; Nakhla S; Tabaja C; Paul A; Wilkoff BL
    J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1382-1392. PubMed ID: 38725252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.